Syntocinon®
Syntocinon® is a pharmaceutical drug with 13 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
5
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
88.9%
8 of 9 finished
11.1%
1 ended early
0
trials recruiting
13
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Oxytocin and Approach-avoid in Grief
Intranasal Oxytocin for Frontotemporal Dementia
Effect of Intranasal Oxytocin on Headache in Chronic Daily Headache
Carbetocin Versus Syntocinon for Prevention of Postpartum Hemorrhage in Cardiac Patients Undergoing Caesarean Section
Intranasal Oxytocin in Hypothalamic Obesity
Clinical Trials (13)
Oxytocin and Approach-avoid in Grief
Intranasal Oxytocin for Frontotemporal Dementia
Effect of Intranasal Oxytocin on Headache in Chronic Daily Headache
Carbetocin Versus Syntocinon for Prevention of Postpartum Hemorrhage in Cardiac Patients Undergoing Caesarean Section
Intranasal Oxytocin in Hypothalamic Obesity
Induction of Labor in Pregnant Women With Prelabor Rupture of Membranes - Oxytocin or Misoprostol
The Effects of Oxytocin on Complex Social Cognition in Autism Spectrum Disorders
Intranasal Oxytocin and Food Intake in Obese Adolescents
Intramuscular Oxytocics: A Randomised Control Trial
Oxytocin and Eating
Short-term Effects of Oxytocin Nasal Spray on Chronic Tinnitus
The Use of Oxytocin, Carbetocin and Buccal Misoprostol in Patients Undergoing Elective Cesarean Section (CS)
Influence of Oxytocin on the Startle Reflex and on Its Modulation
All 13 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 13